Sequentially Site‐Specific Delivery of Apoptotic Protein and Tumor‐Suppressor Gene for Combination Cancer Therapy

• DOI: 10.1002/smll.201902998
• Publication Date: 2019-08-23T06:47:49Z
• Authors: Xiaojie Chen; Qiuwen Zhu; Xiao Xu; Shiyang Shen; Ying Zhang; Ran Mo
• Keywords: Male; Mice, Inbred BALB C; Cell Survival; Optical Imaging; Cytochromes c; Mice, Nude; Antineoplastic Agents; Apoptosis; DNA; 02 engineering and technology; Fluorescence; 3. Good health; Folic Acid; Nanocapsules; Neoplasms; Liposomes; MCF-7 Cells; Animals; Humans; Female; Genes, Tumor Suppressor; Particle Size; 0210 nano-technology

AbstractNanocarrier‐mediated codelivery of multiple anticancer drugs is a potential strategy for enhanced efficacy of combination cancer treatment by unifying differential pharmacokinetic properties and maintaining an optimal ratio of drug cargoes. However, a programmable codelivery system is highly desired to deliver different therapeutics to their specific sites of action to pursue maximized combinational effect. Herein a liposome‐based nanoassembly (p53/C‐rNC/L‐FA) is developed for intracellular site‐specific delivery of an apoptotic protein cytochrome c (CytoC) and a plasmid DNA encoding tumor‐suppressing p53 protein (p53 DNA). p53/C‐rNC/L‐FA consists of an acid‐activated fusogenic liposomal membrane shell modified with folic acid (L‐FA) and a DNA/protein complex core assembled by the p53 DNA, protamine and CytoC‐encapsulated redox‐responsive nanocapsule (C‐rNC). Intratumoral and intraendosomal acidities promote membrane fusion between liposome and biomembrane, resulting in release of the encapsulated p53/C‐rNC complex into the cytoplasm. The cytoplasmic reduction causes degradation of C‐rNC with release of CytoC that induces tumor cell apoptosis. The p53 DNA is transported into the nucleus by the aid of the cationic protamine and thus generates expression of the p53 protein that enhances apoptosis combined with CytoC. p53/C‐rNC/L‐FA is demonstrated to significantly induce tumor cell apoptosis and inhibit tumor growth in the orthotopic breast tumor mouse model.